tiprankstipranks
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market
VSBC
VitaSpring Biomedical
RESEARCH TOOLSreports

VitaSpring Biomedical (VSBC) Financial Statements

3 Followers

VitaSpring Biomedical Financial Overview

VitaSpring Biomedical's market cap is currently $10.35M. The company's EPS TTM is $-0.002; its P/E ratio is -5.60; VitaSpring Biomedical is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jan 26Jan 23Jan 22Jan 21Jan 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 5.61M$ 248.20K$ 15.14K
Gross Profit$ 0.00$ -219.34K$ 2.07M$ 112.20K$ 1.70K
Operating Income$ -385.41K$ -4.18M$ 1.48M$ -425.38K$ -19.49K
EBITDA$ -385.41K$ -3.95M$ 1.49M$ -424.26K$ -19.04K
Net Income$ -415.37K$ -4.16M$ 1.26M$ -425.38K$ 6.92K
Balance Sheet
Cash & Short-Term Investments$ 2.08K$ 29.66K$ 107.21K$ 45.40K$ 0.00
Total Assets$ 14.68K$ 765.95K$ 3.60M$ 189.40K$ 0.00
Total Debt$ 0.00$ 262.98K$ 463.57K$ 0.00$ 0.00
Net Debt$ -2.08K$ 233.32K$ 356.36K$ -45.40K$ 0.00
Total Liabilities$ 4.45M$ 3.16M$ 2.03M$ 93.03K$ 0.00
Stockholders' Equity$ -4.43M$ -2.40M$ 1.58M$ 386.77K$ -18.26K
Cash Flow
Free Cash Flow$ -2.69K$ -77.56K$ 11.81K$ -42.13K$ -105.00
Operating Cash Flow$ -2.69K$ -77.56K$ 84.81K$ -42.13K$ -105.00
Investing Cash Flow$ 0.00$ 0.00$ -73.00K$ 0.00$ 0.00
Financing Cash Flow$ 4.50K$ 0.00$ 50.00K$ 87.53K$ 0.00
Currency in USD

VitaSpring Biomedical Earnings and Revenue History

Income Statement >

VitaSpring Biomedical Debt to Assets

Balance Sheet >

VitaSpring Biomedical Cash Flow

Cash Flow >

VitaSpring Biomedical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >